Combination of Polymyxin Antibiotic and Mobile Colistin Resistant Protein Inhibitor for Treating Superbug
- Field
- Therapeutic Chemicals
- Patent
- IP00856
Key Problem and Market Opportunity
Colistin was used as “last hope” treatment against Gram-negative bacterial infection. However, rapid global resistance towards colistin has emerged. Therefore, there is an urgent need for colistin resistance treatment.
Key Advantages of the Technology
- Gold or silver compounds will work as the mobile colistin resistant proteins inhibitor
- Antibiotics can then enter bacteria with the assistant of such inhibitor ()
Further Details
Runming Wang et al., NATURE COMMUNICATIONS | (2020) 11:5263
Benefits
- Broad spectrum against both carbapenem and colistin resistant bacterial strains
- Can take the advantages of drug repurposing
Potential Product and Services
Drugs for anti-bacteria, especially for treating mobile colistin resistant proteins carrying bacterial infection
Development Status and IP Strength
Patents
- PCT publication no, WO/2021/036923
IP Status
- Patent application submitted